What question did this study set out to answer?

To investigate how IKAROS regulates RAB5B expression in B-cell acute lymphoblastic leukemia.

Epigenetic Regulation of RAB5B in B-Cell Acute Lymphoblastic Leukemia

View Full Paper

Ask AI

Bookmark

Authors

This analysis reveals that IKAROS directly represses RAB5B expression in B-ALL, indicating a novel tumor suppressor mechanism.

To investigate how IKAROS regulates RAB5B expression in B-cell acute lymphoblastic leukemia.
Utilized chromatin immunoprecipitation coupled with next-generation sequencing (ChIP-seq) to analyze RAB5B promoter occupancy.
Confirmed IKAROS binding to the RAB5B promoter using quantitative chromatin immunoprecipitation (qChIP).
Performed gain-of-function and loss-of-function experiments to assess IKAROS's role in RAB5B transcription regulation.
Conducted luciferase reporter assays to investigate transcriptional effects.
IKAROS binding increased at the RAB5B promoter correlated with decreased RAB5B transcription when IKAROS was overexpressed.
Knockdown of IKAROS led to increased RAB5B expression and active chromatin markers, H3K4me3 and H3K27ac, at the promoter.
Primary B-ALL cells with one IKAROS allele deletion exhibited elevated RAB5B levels and active chromatin markers.

Dovat et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark